These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8480481)

  • 21. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
    Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
    Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
    Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia.
    Sunder-Plassmann G; Speiser W; Korninger C; Stain M; Bettelheim P; Pabinger-Fasching I; Lechner K
    Ann Hematol; 1991 May; 62(5):169-73. PubMed ID: 2049463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation.
    Noda A; Wada H; Kusiya F; Sakakura M; Onishi K; Nakatani K; Gabazza EC; Asahara N; Tsukada M; Nobori T; Shiku H
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):265-71. PubMed ID: 12361205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disseminated intravascular coagulation in the early stage after severe burn: the role of excessive thrombin generation].
    Ueyama M; Yamamoto I; Sawada Y
    Nihon Geka Gakkai Zasshi; 1991 Aug; 92(8):907-12. PubMed ID: 1944144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of soluble fibrin in patients with malignancy-associated disseminated intravascular coagulation.
    Nakagawa K; Tsuji H; Masuda H; Yamada K; Yamada Y; Yoneda M; Takada O; Tamagaki T; Yamagami M; Uno M
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):725-30. PubMed ID: 7865678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin?
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):623-7. PubMed ID: 1664251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prothrombin fragment 1 + 2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients.
    Gruden G; Cavallo-Perin P; Romagnoli R; Olivetti C; Frezet D; Pagano G
    Diabet Med; 1994 Jun; 11(5):485-8. PubMed ID: 8088128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K; Okamoto K
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
    Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
    Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum des-R prothrombin activation peptide fragment 2: a novel prognostic marker for disseminated intravascular coagulation.
    Chung S; Kim JE; Kim HK; Yeon EH; Shin YS; Kim CW
    Thromb Res; 2013 Jun; 131(6):547-53. PubMed ID: 23664563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of tissue factor in disseminated intravascular coagulation.
    Asakura H; Kamikubo Y; Goto A; Shiratori Y; Yamazaki M; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E
    Thromb Res; 1995 Nov; 80(3):217-24. PubMed ID: 8578548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
    Asakura H; Hifumi S; Jokaji H; Saito M; Kumabashiri I; Uotani C; Morishita E; Yamazaki M; Shibata K; Mizuhashi K
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):469-73. PubMed ID: 1420823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A microtitre plate ELISA to measure thrombin-antithrombin complex using pan-specific antibodies.
    Boisclair MD; Lane DA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):795-802. PubMed ID: 1489901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
    Mosad E; Elsayh KI; Eltayeb AA
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.